@article{f293b2a746e14ba3bc543818b3056603,
title = "Association between reactogenicity and SARS-CoV-2 antibodies after the second dose of the BNT162b2 COVID-19 vaccine",
abstract = "High vaccine reactogenicities may reflect stronger immune responses, but the epidemiological evidence for coronavirus disease 2019 (COVID-19) vaccines is sparse and inconsistent. We observed that a fever of ≥38℃ after two doses of the BNT162b2 vaccine was associated with higher severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike IgG titers.",
keywords = "BNT162b2 vaccine, Fever, Reactogenicity, SARS-CoV-2, Spike IgG titer",
author = "Shohei Yamamoto and Ami Fukunaga and Akihito Tanaka and Takeuchi, {Junko S.} and Yosuke Inoue and Moto Kimura and Kenji Maeda and Gohzoh Ueda and Tetsuya Mizoue and Mugen Ujiie and Wataru Sugiura and Norio Ohmagari",
note = "Funding Information: This work was funded by Abbott Japan (grant number 20C050), the NCGM COVID-19 Gift Fund (grant number 19K059), the Japan Health Research Promotion Bureau Research Fund (grant number 2020-B-09), and a grant from the National Center for Global Health and Medicine (grant number 21A006). Publisher Copyright: {\textcopyright} 2022 Elsevier Ltd",
year = "2022",
month = mar,
day = "18",
doi = "10.1016/j.vaccine.2022.02.052",
language = "English",
volume = "40",
pages = "1924--1927",
journal = "Vaccine",
issn = "0264-410X",
publisher = "Elsevier BV",
number = "13",
}